🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Effectiveness of adding montelukast to inhaled corticosteroids in adult sub...
Status
Completed
Location
Multiple Locations
Start Date
2007-04-01
Trial ID
NCT00545844
Treatments Being Tested
Primary Objective: To investigate effects of SAR440340 (anti-interleukin-3...
Status
Completed
Location
Investigational Site Number 8400002
Start Date
2018-07-16
Trial ID
NCT03546907
Treatments Being Tested
The purpose of this study is to assess the evolution of disease control, he...
Status
Active Not Recruiting
Location
Centro de Salud de Jerez Sur
Start Date
2017-07-26
Trial ID
NCT04480242
This is a multi-center, open-label, long-term study of subcutaneously (SC) ...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-05-29
Trial ID
NCT02135692
Treatments Being Tested
This is a randomised controlled study to evaluate the effect of providing p...
Status
Completed
Location
NHS Greater Glasgow and Clyde
Start Date
2015-07
Trial ID
NCT02512198
Treatments Being Tested
The purpose of this study is to determine if the addition of preventive med...
Status
Completed
Location
Ohio University
Start Date
2001-07
Trial ID
NCT00910689
This study is testing a new way to help adults with asthma get follow up ca...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-06
Trial ID
NCT07396987
Treatments Being Tested
The primary objective is to compare the effectiveness of maintenance therap...
Status
Completed
Location
HealthCore, Inc.
Start Date
2019-11-01
Trial ID
NCT04138758
Treatments Being Tested
Background: The most common asthma drugs, namely inhaled glucocorticoids (...
Status
Completed
Location
Kuopio University Hospital
Start Date
2012-10
Trial ID
NCT01961154
Treatments Being Tested
Primary Objective: To evaluate the efficacy of dupilumab administered ever...
Status
Completed
Location
Cullman Research Center, LLC Site Number : 8400095
Start Date
2020-07-06
Trial ID
NCT04456673